Please refer the attached Intimation.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transchem Limited's board approved raising the authorised share capital from ₹30 crore to ₹75 crore (divided into 7.5 crore equity shares of ₹10 each), requiring an amendment to the MOA and shareholder approval. The board also cleared a Section 186 borrowing/investment limit of ₹250 crore. Most significantly, it approved a preferential issue of up to 6.15 crore warrants at ₹75 each, aggregating up to ₹461.25 crore, to four non-promoter allottees: Bakkt Opco Holdings LLC (4.75 crore warrants), Pishu Chainani (1.20 crore), JVS Holdings LLP (16 lakh), and Dhawal Mehta (4 lakh). If all warrants are exercised, these allottees will collectively hold about 83.4% of the company, indicating a near-complete change in ownership. All three items need shareholder nod at an EGM scheduled for December 20, 2025 via video conferencing, with 25% payable upfront and 75% on conversion within 18 months.
This is a high-dilution event: existing shareholders could see their stake shrink dramatically as new non-promoter investors take roughly 83% of the company post-exercise. It signals a likely change in control, and shareholders should carefully evaluate the EGM agenda on December 20, 2025 before deciding on the proposed preferential allotment.